Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 15 | 2024 | 755 | 3.130 |
Why?
|
| Indians, North American | 15 | 2024 | 511 | 2.920 |
Why?
|
| Heart Defects, Congenital | 3 | 2019 | 92 | 1.750 |
Why?
|
| Oklahoma | 26 | 2023 | 973 | 1.670 |
Why?
|
| Papillomavirus Infections | 5 | 2023 | 137 | 1.410 |
Why?
|
| Infertility | 3 | 2019 | 35 | 1.370 |
Why?
|
| Healthcare Disparities | 3 | 2019 | 78 | 1.310 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2019 | 17 | 1.270 |
Why?
|
| Environmental Exposure | 3 | 2021 | 47 | 1.190 |
Why?
|
| Benzene | 2 | 2018 | 11 | 1.190 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 16 | 1.150 |
Why?
|
| Air Pollution | 2 | 2018 | 13 | 1.150 |
Why?
|
| Registries | 15 | 2022 | 383 | 0.980 |
Why?
|
| Child | 14 | 2022 | 2147 | 0.940 |
Why?
|
| Humans | 47 | 2024 | 26827 | 0.940 |
Why?
|
| Female | 35 | 2024 | 14463 | 0.900 |
Why?
|
| Infant | 11 | 2019 | 957 | 0.890 |
Why?
|
| Vaccines | 1 | 2023 | 30 | 0.850 |
Why?
|
| Population Surveillance | 4 | 2019 | 85 | 0.840 |
Why?
|
| Health Services Accessibility | 2 | 2023 | 90 | 0.790 |
Why?
|
| United States | 17 | 2024 | 2033 | 0.740 |
Why?
|
| Papillomavirus Vaccines | 4 | 2022 | 53 | 0.720 |
Why?
|
| Child, Preschool | 10 | 2019 | 1091 | 0.710 |
Why?
|
| Male | 26 | 2024 | 12870 | 0.680 |
Why?
|
| Adult | 22 | 2024 | 7383 | 0.660 |
Why?
|
| Water Pollution | 1 | 2018 | 7 | 0.640 |
Why?
|
| Natural Gas | 1 | 2018 | 6 | 0.640 |
Why?
|
| Infant, Newborn | 8 | 2018 | 843 | 0.620 |
Why?
|
| Cleft Palate | 1 | 2018 | 12 | 0.620 |
Why?
|
| Young Adult | 13 | 2024 | 2581 | 0.610 |
Why?
|
| Neural Tube Defects | 1 | 2018 | 19 | 0.610 |
Why?
|
| Adolescent | 13 | 2021 | 2957 | 0.610 |
Why?
|
| Paint | 1 | 2017 | 1 | 0.570 |
Why?
|
| Paternal Exposure | 1 | 2017 | 1 | 0.570 |
Why?
|
| Hepatoblastoma | 1 | 2017 | 6 | 0.570 |
Why?
|
| Environmental Pollutants | 1 | 2017 | 32 | 0.560 |
Why?
|
| Maternal Exposure | 1 | 2017 | 16 | 0.560 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 36 | 0.560 |
Why?
|
| Occupational Exposure | 1 | 2017 | 25 | 0.550 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2017 | 32 | 0.550 |
Why?
|
| Aged | 17 | 2024 | 5167 | 0.530 |
Why?
|
| Vehicle Emissions | 1 | 2016 | 4 | 0.530 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 3 | 0.530 |
Why?
|
| Leukemia | 1 | 2016 | 22 | 0.530 |
Why?
|
| Air Pollutants | 1 | 2016 | 14 | 0.520 |
Why?
|
| Cancer Survivors | 1 | 2016 | 39 | 0.510 |
Why?
|
| Middle Aged | 18 | 2024 | 6818 | 0.500 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 164 | 0.490 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 442 | 0.470 |
Why?
|
| African Americans | 4 | 2020 | 350 | 0.460 |
Why?
|
| Case-Control Studies | 5 | 2022 | 700 | 0.440 |
Why?
|
| Qualitative Research | 2 | 2024 | 172 | 0.430 |
Why?
|
| Incidence | 10 | 2024 | 545 | 0.420 |
Why?
|
| Logistic Models | 4 | 2017 | 397 | 0.410 |
Why?
|
| Body Weight | 1 | 2012 | 246 | 0.360 |
Why?
|
| Diabetes, Gestational | 2 | 2022 | 63 | 0.360 |
Why?
|
| Retrospective Studies | 6 | 2019 | 2433 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 507 | 0.350 |
Why?
|
| Health Care Surveys | 3 | 2019 | 67 | 0.350 |
Why?
|
| Geographic Mapping | 2 | 2020 | 6 | 0.340 |
Why?
|
| Pregnancy | 5 | 2022 | 1131 | 0.340 |
Why?
|
| Proportional Hazards Models | 2 | 2023 | 213 | 0.330 |
Why?
|
| Geographic Information Systems | 2 | 2020 | 18 | 0.320 |
Why?
|
| Mortality | 2 | 2019 | 43 | 0.320 |
Why?
|
| Residence Characteristics | 2 | 2020 | 101 | 0.310 |
Why?
|
| Early Detection of Cancer | 3 | 2019 | 121 | 0.300 |
Why?
|
| Prevalence | 3 | 2019 | 472 | 0.290 |
Why?
|
| SEER Program | 5 | 2024 | 46 | 0.290 |
Why?
|
| Survival Analysis | 3 | 2016 | 276 | 0.280 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2020 | 277 | 0.270 |
Why?
|
| Risk Factors | 3 | 2023 | 2011 | 0.260 |
Why?
|
| Odds Ratio | 2 | 2017 | 230 | 0.260 |
Why?
|
| Obesity | 1 | 2012 | 650 | 0.260 |
Why?
|
| Alaska Natives | 1 | 2024 | 2 | 0.240 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 1927 | 0.230 |
Why?
|
| Poverty | 1 | 2024 | 81 | 0.230 |
Why?
|
| Mass Screening | 1 | 2024 | 141 | 0.220 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 98 | 0.220 |
Why?
|
| Pilot Projects | 1 | 2024 | 390 | 0.210 |
Why?
|
| Travel | 1 | 2023 | 12 | 0.210 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 456 | 0.210 |
Why?
|
| Parabens | 1 | 2022 | 5 | 0.200 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 11 | 0.190 |
Why?
|
| Interviews as Topic | 2 | 2024 | 150 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 357 | 0.190 |
Why?
|
| Electronic Health Records | 1 | 2022 | 59 | 0.190 |
Why?
|
| Research | 1 | 2022 | 88 | 0.190 |
Why?
|
| Arsenicals | 1 | 2021 | 5 | 0.190 |
Why?
|
| Arsenic | 1 | 2021 | 19 | 0.180 |
Why?
|
| Vaccination | 4 | 2024 | 167 | 0.180 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 111 | 0.180 |
Why?
|
| Health Behavior | 1 | 2022 | 154 | 0.180 |
Why?
|
| Metabolomics | 1 | 2021 | 79 | 0.180 |
Why?
|
| Age Distribution | 2 | 2017 | 70 | 0.170 |
Why?
|
| Topography, Medical | 1 | 2020 | 2 | 0.170 |
Why?
|
| Delayed Diagnosis | 2 | 2016 | 18 | 0.170 |
Why?
|
| Cohort Studies | 2 | 2019 | 858 | 0.170 |
Why?
|
| Documentation | 1 | 2019 | 24 | 0.170 |
Why?
|
| Hotlines | 1 | 2019 | 29 | 0.160 |
Why?
|
| Medicaid | 2 | 2016 | 52 | 0.160 |
Why?
|
| Social Class | 1 | 2019 | 78 | 0.160 |
Why?
|
| Health Services | 1 | 2019 | 12 | 0.160 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 8 | 0.160 |
Why?
|
| Spatial Analysis | 1 | 2018 | 8 | 0.160 |
Why?
|
| Population Density | 1 | 2018 | 21 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 910 | 0.150 |
Why?
|
| Regression Analysis | 1 | 2018 | 209 | 0.150 |
Why?
|
| Pregnancy Rate | 1 | 2018 | 45 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 133 | 0.150 |
Why?
|
| Insemination, Artificial | 1 | 2018 | 23 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2022 | 1217 | 0.140 |
Why?
|
| Walk Test | 1 | 2017 | 20 | 0.140 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 7 | 0.140 |
Why?
|
| Gasoline | 1 | 2017 | 9 | 0.140 |
Why?
|
| Solvents | 1 | 2017 | 38 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 128 | 0.140 |
Why?
|
| Age Factors | 2 | 2016 | 716 | 0.140 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 4 | 0.140 |
Why?
|
| Exercise Tolerance | 1 | 2017 | 82 | 0.130 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 15 | 0.130 |
Why?
|
| Motor Vehicles | 1 | 2016 | 5 | 0.130 |
Why?
|
| Rural Population | 2 | 2020 | 89 | 0.130 |
Why?
|
| Medically Uninsured | 1 | 2016 | 30 | 0.130 |
Why?
|
| Survivors | 1 | 2016 | 36 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 37 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 189 | 0.130 |
Why?
|
| Acute Disease | 1 | 2016 | 153 | 0.130 |
Why?
|
| Walking | 1 | 2017 | 130 | 0.130 |
Why?
|
| Standard of Care | 1 | 2015 | 11 | 0.130 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 52 | 0.130 |
Why?
|
| Mastectomy, Segmental | 1 | 2015 | 18 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2017 | 113 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 118 | 0.120 |
Why?
|
| Melanoma | 1 | 2016 | 128 | 0.120 |
Why?
|
| Guideline Adherence | 1 | 2015 | 91 | 0.120 |
Why?
|
| Smoking Cessation | 1 | 2019 | 398 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 980 | 0.110 |
Why?
|
| Sex Distribution | 3 | 2016 | 76 | 0.100 |
Why?
|
| Social Environment | 1 | 2012 | 56 | 0.100 |
Why?
|
| Overweight | 1 | 2012 | 110 | 0.090 |
Why?
|
| Time Factors | 3 | 2019 | 1562 | 0.090 |
Why?
|
| Students | 1 | 2012 | 188 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2018 | 250 | 0.060 |
Why?
|
| Health Status Disparities | 2 | 2016 | 60 | 0.060 |
Why?
|
| Trust | 1 | 2024 | 21 | 0.060 |
Why?
|
| Universities | 1 | 2024 | 115 | 0.050 |
Why?
|
| Causality | 1 | 2023 | 13 | 0.050 |
Why?
|
| Phenol | 1 | 2022 | 7 | 0.050 |
Why?
|
| Phenols | 1 | 2022 | 22 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 23 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 90 | 0.050 |
Why?
|
| Tooth, Deciduous | 1 | 2021 | 6 | 0.050 |
Why?
|
| Cacodylic Acid | 1 | 2021 | 5 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 21 | 0.050 |
Why?
|
| Immunization | 1 | 2021 | 118 | 0.050 |
Why?
|
| Alaska | 1 | 2020 | 38 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Cause of Death | 1 | 2019 | 66 | 0.040 |
Why?
|
| Urban Population | 1 | 2020 | 70 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 733 | 0.040 |
Why?
|
| Censuses | 1 | 2018 | 3 | 0.040 |
Why?
|
| Texas | 1 | 2018 | 133 | 0.040 |
Why?
|
| Asian Americans | 1 | 2018 | 40 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 406 | 0.040 |
Why?
|
| Linear Models | 1 | 2017 | 201 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 298 | 0.030 |
Why?
|
| Rectal Neoplasms | 1 | 2016 | 8 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 118 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 759 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 472 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 445 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 116 | 0.030 |
Why?
|
| Medicare | 1 | 2015 | 118 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 242 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 270 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 338 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2264 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 9960 | 0.020 |
Why?
|